IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.771
AS - Asia 6.087
EU - Europa 3.269
SA - Sud America 1.987
AF - Africa 387
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
AN - Antartide 1
Totale 19.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.453
SG - Singapore 2.535
BR - Brasile 1.483
UA - Ucraina 1.265
VN - Vietnam 1.132
CN - Cina 1.004
DE - Germania 692
FR - Francia 292
SE - Svezia 270
IT - Italia 254
BD - Bangladesh 242
TR - Turchia 215
HK - Hong Kong 189
AR - Argentina 178
CA - Canada 166
KR - Corea 157
IN - India 115
SN - Senegal 115
EC - Ecuador 102
AT - Austria 98
RU - Federazione Russa 88
FI - Finlandia 85
IQ - Iraq 78
ZA - Sudafrica 78
MX - Messico 76
ID - Indonesia 68
CO - Colombia 52
PK - Pakistan 51
GB - Regno Unito 50
VE - Venezuela 44
CL - Cile 40
UZ - Uzbekistan 39
MA - Marocco 36
PY - Paraguay 34
TN - Tunisia 30
MY - Malesia 28
BE - Belgio 27
KE - Kenya 27
DZ - Algeria 26
UY - Uruguay 26
PL - Polonia 22
SA - Arabia Saudita 21
EG - Egitto 19
KZ - Kazakistan 19
ES - Italia 18
NL - Olanda 18
AL - Albania 17
JO - Giordania 17
JP - Giappone 17
ET - Etiopia 16
NP - Nepal 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
OM - Oman 14
PE - Perù 14
BO - Bolivia 12
HN - Honduras 12
LB - Libano 12
PA - Panama 12
AZ - Azerbaigian 11
CR - Costa Rica 11
NI - Nicaragua 11
PS - Palestinian Territory 11
RO - Romania 11
EU - Europa 10
IE - Irlanda 8
BY - Bielorussia 7
GE - Georgia 7
GT - Guatemala 7
NG - Nigeria 7
SY - Repubblica araba siriana 7
AU - Australia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
IL - Israele 6
JM - Giamaica 6
LV - Lettonia 6
AO - Angola 5
GA - Gabon 5
IR - Iran 5
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
DK - Danimarca 4
KW - Kuwait 4
LK - Sri Lanka 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
TZ - Tanzania 4
BH - Bahrain 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
GR - Grecia 3
LT - Lituania 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TG - Togo 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
Totale 19.476
Salva come PNG Salva come JPEG
Città #
Dallas 1.460
Singapore 948
Jacksonville 866
Chandler 607
San Jose 536
Dearborn 447
Boardman 435
Ho Chi Minh City 395
San Mateo 341
Ashburn 310
Hanoi 259
Beijing 257
Council Bluffs 256
Lauterbourg 187
Lawrence 186
Roxbury 182
Izmir 180
New York 172
Seoul 156
Hefei 143
Shanghai 137
São Paulo 134
Des Moines 118
Dakar 115
Hong Kong 115
Ottawa 113
Cambridge 83
Helsinki 76
Ann Arbor 66
Wilmington 66
Vienna 65
Brooklyn 60
Los Angeles 60
Da Nang 55
Grafing 51
Haiphong 50
Ogden 48
Rio de Janeiro 47
Guayaquil 42
Tashkent 34
Brasília 30
Inglewood 30
Rome 30
Belo Horizonte 28
Johannesburg 28
Tianjin 28
Quito 27
Seattle 27
Rende 26
Baghdad 25
Columbus 25
Santa Clara 25
Biên Hòa 24
Porto Alegre 24
Nairobi 23
Brussels 22
Curitiba 22
Montevideo 22
Munich 22
Salvador 22
Hải Dương 21
Dhaka 20
Guarulhos 20
Thái Nguyên 20
Bogotá 19
Chicago 19
San Francisco 19
Toronto 19
Buenos Aires 18
Asunción 17
Guangzhou 17
Amman 16
Cape Town 16
Ribeirão Preto 16
Tokyo 16
Amsterdam 15
Boston 15
Bắc Ninh 15
London 15
Moscow 15
Warsaw 15
Caracas 14
Medellín 14
Orem 14
Santiago 14
Strasbourg 14
Chennai 13
Goiânia 13
Milan 13
Ninh Bình 13
Can Tho 12
Casablanca 12
Erbil 12
Kuala Lumpur 12
Panama City 12
Phoenix 12
Tunis 12
Addis Ababa 11
Betim 11
Campinas 11
Totale 10.970
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 1.506
Carbazole Derivatives as Antiviral Agents: An Overview 244
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 183
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 174
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 167
Identification of chlorocarbazole derivatives as potential antiviral agents. 166
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 158
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 148
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 147
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 146
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 145
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 143
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 142
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 142
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 137
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 136
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 135
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 133
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 133
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 131
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 130
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 129
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 129
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 126
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 125
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 123
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 120
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 119
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 119
CARBAZOLE DERIVATIVES TARGETING HUMAN TOPOISOMERASES I AND ACTIN IN BREAST CANCER TREATMENT 115
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 112
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 109
Cytokines in HIV infection 106
The Ongoing Impact of COVID-19 on Pediatric Obesity 105
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 105
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 104
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 103
When Chirality Makes the Difference: The Case of Novel Enantiopure N-Heterocyclic Carbene–Gold and –Silver Complexes 103
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 102
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 102
Antiviral activity of nucleoside analogues in macrophages 101
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 99
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 99
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 99
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 99
Understanding HIV compartments and reservoirs. 98
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 97
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 97
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 96
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 94
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 94
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 94
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 93
Triclosan: A Small Molecule with Controversial Roles 92
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 92
Therapeutic strategies towards HIV-1 infection in macrophages 92
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 92
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 92
Ru-NHC complexes with a broad spectrum of biological activities. 91
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 91
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 90
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 90
oxidative stress and HIV infection:target pathways for novel therapies? 90
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 89
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 89
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 89
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 89
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 89
Influenza virus A (H5N1): a pandemic risk? 88
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 88
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 88
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 87
GM-CSF and M-CSF modulate the replication of HIV and other viruses in primary macrophages by acting on different steps of virus lifecycle 87
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 87
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 86
Le basi razionali della terapia di associazione nel trattamento dell’AIDS 86
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 86
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 86
Dinamica virale nei reservoirs. Infezioni da HIV: approfondimenti sul tema 85
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 85
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 84
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 84
Attività anti-HIV di differenti classi di farmaci antivirali di interesse clinico: valutazione in vitro dell’efficacia in monociti/macrofagi primari e linfociti 84
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 84
Development of HIV mutations in human primary macrophages under RT inhibitors treatment does non confer drug resistance 84
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 84
Chirality influences the biological properties of novel NHC-gold and -silver complexes 83
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 83
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 83
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 83
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 83
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 82
Phylogenetic analysis of the surface proteins of influenza A (H5N1) viruses isolated in Asian and African populations 82
Inhibition of HIV replication in primary macrophages by antiviral drugs: Modulation by cytokines and comparative efficacy in lymphocytes 82
The Treatment with the Fusion Inhibitor Enfuvirtide Influences the Appearance of Mutations in the HIV-1 Regulatory Protein Rev 82
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 82
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype. 81
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 81
Latent infection of human herpesvirus type-7 in macrophage 80
HIV-1-mediated apoptosis occurs in macrophages infected by X4, but not by R5 viruses 80
Totale 12.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.796
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 0 0 164
2021/20221.552 18 165 4 112 139 61 12 405 34 9 201 392
2022/20231.536 224 110 51 182 155 134 2 221 236 47 112 62
2023/2024888 88 25 56 27 48 172 22 35 108 30 47 230
2024/20252.377 141 458 52 93 129 107 75 132 435 137 202 416
2025/20269.779 1.170 579 1.610 1.159 1.731 460 931 425 416 635 277 386
Totale 19.614